Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


11.02.2019

1 Arch Virol
1 J Gen Virol
1 J Infect
15 J Infect Dis
1 J Virol
1 Lancet
1 PLoS Biol
1 PLoS Comput Biol
3 Proc Natl Acad Sci U S A
4 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. ZHU D, Lok C, Chao S, Chen L, et al
    Detection and characterization of type B influenza virus from influenza-like illness cases during the 2017-2018 winter influenza season in Beijing, China.
    Arch Virol. 2019 Feb 7. pii: 10.1007/s00705-019-04160.
    PubMed     Text format     Abstract available


    J Gen Virol

  2. POWELL TJ, Rijal P, McEwen-Smith RM, Byun H, et al
    A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    J Gen Virol. 2019 Feb 4. doi: 10.1099/jgv.0.001228.
    PubMed     Text format     Abstract available


    J Infect

  3. HU J, Zha Y, Jin X, Wen X, et al
    Continuous adaptation of the HA and NA gene of H3N2 subtypes of avian influenza virus in South China, 2017-2018.
    J Infect. 2019 Jan 30. pii: S0163-4453(19)30031.
    PubMed     Text format    


    J Infect Dis

  4. NEUMANN G, Kawaoka Y
    Can We Predict The Next Influenza Pandemics?
    J Infect Dis. 2019 Jan 31. pii: 5304929. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. SAELENS X
    The Role of M2e in the Development of Universal Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. EICHELBERGER MC, Monto AS
    Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
    J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. KRAMMER F, Palese P
    Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
    J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. MORENS DM, Taubenberger JK
    Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
    J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
    PubMed     Text format    

  9. ORTIZ JR, Neuzil KM
    Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. CROWE JE JR
    Antibody Determinants of Influenza Immunity.
    J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. SANT AJ
    The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
    J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. ROSS TM
    Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
    J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
    Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
    J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
    Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
    J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. PAULES CI, Fauci AS
    Influenza Vaccines: Good, But We Can Do Better.
    J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
    PubMed     Text format    

  16. SAAD-ROY CM, McDermott AB, Grenfell BT
    Dynamic perspectives on the search for a universal influenza vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. CRANK MC, Mascola JR, Graham BS
    Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
    PubMed     Text format    

  18. RUDRARAJU R, Mordant F, Subbarao K
    How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
    PubMed     Text format    


    J Virol

  19. TESINI BL, Kanagaiah P, Wang J, Hahn M, et al
    Broad hemagglutinin-specific memory B cell expansion by seasonal influenza virus infection reflects early-life imprinting and adaptation to the infecting virus.
    J Virol. 2019 Feb 6. pii: JVI.00169-19. doi: 10.1128/JVI.00169.
    PubMed     Text format     Abstract available


    Lancet

  20. BARNETT R
    Influenza.
    Lancet. 2019;393:396.
    PubMed     Text format    


    PLoS Biol

  21. TURNER HL, Pallesen J, Lang S, Bangaru S, et al
    Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains.
    PLoS Biol. 2019;17:e3000139.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  22. OSTHUS D, Daughton AR, Priedhorsky R
    Even a good influenza forecasting model can benefit from internet-based nowcasts, but those benefits are limited.
    PLoS Comput Biol. 2019;15:e1006599.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  23. YAMAUCHI Y
    Quantum dots crack the influenza uncoating puzzle.
    Proc Natl Acad Sci U S A. 2019 Jan 31. pii: 1822089116.
    PubMed     Text format    

  24. LIU QH, Ajelli M, Aleta A, Merler S, et al
    Measurability of the epidemic reproduction number in data-driven contact networks.
    Proc Natl Acad Sci U S A. 2018;115:12680-12685.
    PubMed     Text format     Abstract available

  25. MORIYAMA M, Ichinohe T
    High ambient temperature dampens adaptive immune responses to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1815029116.
    PubMed     Text format     Abstract available


    Vaccine

  26. RAO S, Alishahi M, De Crescenzo L, Dempsey AF, et al
    A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016.
    Vaccine. 2019 Feb 2. pii: S0264-410X(19)30130.
    PubMed     Text format     Abstract available

  27. SHAPIRO JR, Hodgins B, Hendin HE, Patel A, et al
    Needle-free delivery of influenza vaccine using the Med-Jet(R) H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30103.
    PubMed     Text format     Abstract available

  28. WESTRICK SC, Patterson BJ, Kader MS, Rashid S, et al
    National survey of pharmacy-based immunization services.
    Vaccine. 2018;36:5657-5664.
    PubMed     Text format     Abstract available

  29. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: